Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginFCF MarginNet MarginOperating MarginReturn on Sales

Cogent Biosciences (COGT) Assets Average (2018 - 2021)

Cogent Biosciences has reported Assets Average over the past 4 years, most recently at $222.0 million for Q3 2021.

  • Quarterly results put Assets Average at $222.0 million for Q3 2021, up 159.71% from a year ago — trailing twelve months through Sep 2021 was $222.0 million (up 159.71% YoY), and the annual figure for FY2020 was $150.2 million, up 121.9%.
  • Assets Average for Q3 2021 was $222.0 million at Cogent Biosciences, down from $233.1 million in the prior quarter.
  • Over the last five years, Assets Average for COGT hit a ceiling of $244.3 million in Q1 2021 and a floor of $35.0 million in Q2 2020.
  • Median Assets Average over the past 4 years was $83.6 million (2019), compared with a mean of $109.6 million.
  • Biggest five-year swings in Assets Average: tumbled 53.52% in 2020 and later skyrocketed 565.95% in 2021.
  • Cogent Biosciences' Assets Average stood at $90.4 million in 2018, then tumbled by 40.62% to $53.7 million in 2019, then surged by 264.18% to $195.4 million in 2020, then grew by 13.59% to $222.0 million in 2021.
  • The last three reported values for Assets Average were $222.0 million (Q3 2021), $233.1 million (Q2 2021), and $244.3 million (Q1 2021) per Business Quant data.